Abstract: Optogenetics and photopharmacology enable the spatiotemporal control of cell and animal behavior by light. Red light offers deep tissue penetration and minimal phototoxicity, but very few red light-sensitive optogenetic methods are currently available. Here, we developed a red light-induced homodimerization domain. We first showed that an optimized sensory domain of the cyanobacterial phytochrome 1 (CPH1) can be expressed robustly and without cytotoxicity in human cells. We then applied this domain to induce dimerization of two receptor tyrosine kinases, the fibroblast growth factor receptor 1 and the neurotrophin receptor trkB. With this new optogenetic method in hand, we activated the MAPK/ERK pathway non-invasively in mammalian tissue and developed multi-color cell signaling experiments. The light-controlled dimerizer and the red light-activated receptor tyrosine kinases will prove useful to regulate a variety of cellular processes with light.
Optogenetics has revolutionized neuroscience and cell biology by providing optical, thus spatially and temporally precise, means to decode molecular and cellular networks. Light regulation of protein function is often achieved through genetically engineered intra-or intermolecular (un-)binding reactions. [1] For instance, in the light-activated GTPase Rac1 [2] , a C-terminal helix dissociates from its light-oxygen-voltage sensing (LOV) domain core to release inhibition of enzyme function. In light-activated gene regulation and membrane recruitment, LOV domains either homodimerize or cryptochromes heterodimerize with interacting factors in functionally relevant complexes. [3] In these photoreceptors, flavin cofactors (flavin mononucleotide or flavin adenine dinucleotide) endowing sensitivity to blue light ( Figure 1a ). However, blue light overlaps with wavelengths used for imaging of many fluorophores and exhibits limited tissue penetration. Application of red light can overcome these limitations but is restricted to reactions of cyclic (di)nucleotides or heterodimerization. [4] Here, we extended the arsenal of light-controlled reactions with a red light-sensing homodimerizer, which we repurposed from the cyanobacterial phytochrome 1 (CPH1) of Synechocystis and applied to activate membrane receptors orthogonally from fluorescent proteins and in mammalian tissue.
Phytochromes form a diverse protein family in microbes and plants that senses light through bound linear tetrapyrroles ( Figure 1a) . [5] In particular, some phytochromes, including CPH1, are converted between red light-absorbing Pr states and far red light-absorbing Pfr states. In vitro, the sensory module of CPH1 (CPH1S; Figure 1b) , which corresponds to the C-terminally truncated protein, was shown to undergo light-dependent changes in oligomerization state. [6] Red light resulted in the homodimeric Pfr state and far red light in the monomeric Pr state ( Figure 1c ). We hypothesized that this domain may be developed into a new tool to control protein-protein interactions by red light in mammalian cells. Because CPH1S was not expressed in mammalian cells previously, we tested if its biogenesis is harmonious with mammalian protein production in human embryonic kidney 293 (HEK293) cells. We first fused a 1539 basepair-fragment (CPH1S) from genomic DNA to the bright yellow fluorescent protein mVenus, which allowed for quantification of CPH1S expression in the context of a fusion protein. We observed weak fluorescence in HEK293 cells transfected with mVenus-CPH1S (Figure 1d ), indicative of poor protein expression that may impede its straight-forward use. We reasoned that limited expression might originate from divergent codon usage of the cyanobacterial gene and mammalian host cells. [7] Indeed, a synthetic codon-optimized variant of the gene (CPH1S-o) showed increased expression without measurable cytotoxicity (Figure 1d and e) .
Homodimerization underlies the function of diverse protein families, such as kinases, cadherins, antibodies, motor proteins and transcription factors. For instance, for many receptor tyrosine kinases (RTKs) previously it was shown that homodimerization is required and can be sufficient for initiation of downstream signaling pathways, such as mitogen-activated protein kinases/extracellular signal-regulated kinase (MAPK/ERK) or phosphatidylinositol-3 kinase/Akt (PI3K/Akt) pathways. [8] To create a red light-activated RTK, we fused CPH1S-o to the far C-terminus of the murine fibroblast growth factor receptor 1 (mFGFR1) (Figure 2a ). At this position, chemical homodimerization domains, such as an engineered FK506 binding protein (FKBP), or fluorescent proteins were previously incorporated.
[9] The extracellular domain of the receptor was replaced by a myristoylation domain to obtain a receptor that is inert to its natural ligands. [9a,10] We next examined the ability of mFGFR1-CPH1S-o to activate the MAPK/ERK pathway in response to red light in HEK293 cells. Cells supplemented with the tetrapyrrole phycocyanobillin (PCB) responded to dim red light (I = 6.2 µW cm -2 ,   630 ± 5 nm) with strong pathway activation as measured using a transcriptional reporter (Figure 2b) . Control experiments showed that (i) blue (I = 150 µW cm -2 ,   470 ± 5 nm) or green (I = 6.2 µW cm -2 ,   530 ± 5 nm) light did not result in pathway activation, (ii) red light had no effect after loss of kinase activity (Y271F and Y272F mutations) or on a fusion protein of mFGFR1 and FKBP ( Figure  2b) . Notably, the results obtained on mFGFR1-FKBP indicated absence of receptor dimerization of mFGFR1-CPH1S-o in the dark. Finally, substituting a conserved arginine (R195) in the mFGFR1 catalytic domain with a negative charge, which prevents formation of an essential, asymmetric kinase domain dimer [11] , abolished pathway activation, indicating that dimerization is required for receptor activation by CPH1S-o (Figure 2b) . We extended this design principle to a second RTK, the rat neurotrophin receptor trkB (rtrkB). Also in this case, red light resulted in pathway activation (Figure 2c ) that depended on PCB ( Figure S1 ). Immunoblotting demonstrated that activation of the MAPK/ERK and PI3K/Akt pathways returned to basal levels  30 min after light illumination ( Figure S2 ). Overall, incorporation of CPH1S-o, but not of other cyano-or proteobacterial phytochromes ( Figure S3 ), into RTKs enabled activation of the receptors and key pathways by red light.
Light absorbed by CPH1 and other phytochromes is redshifted compared to that absorbed by many fluorescent proteins (e.g. typical blue, green and red fluorescent proteins are excited at  440, 490 and 560 nm, resp.). This property has been taken advantage of in studies that applied phytochromes as spectrallyseparated fluorophores in multi-color imaging [12] Inspired by this work, we explored whether CPH1S-o can be combined with fluorescent proteins (e.g., mCerulean3:  Ex/Em = 433 / 475 nm, mCherry:  Ex/Em = 587 / 610 nm).
[13] The goal of these experiments was optical actuation of cells (CPHS1-o), combined with optical detection of their signaling state (the first fluorescent protein) and viability (the second fluorescent protein) (Figure 2d ). We first engineered transcriptional fluorescent reporters of the MAPK/ERK pathway in which mCerulean3 or mCherry were under control of the pathway-sensitive serum response element (SRE). [14] We next tested whether these proteins are indeed spectrally separated from red light used for CPH1S-o activation. As expected, we found that red light did not result in bleaching of these two proteins ( Figure S4 ), and thus the reporters can faithfully detect pathway activation by mFGFR1-CPH1S-o (Figure 2e ). Using the three components, we went on to demonstrate that light-induced cell signaling can be detected separately from cell viability in the same experiment. We prepared a viability reporter in which mCerulean3 was under the control of the constitutively active cytomegalovirus (CMV) promoter, and then applied this viability reporter in combination with the mCherry MAPK/ERK pathway reporter. We incubated cells either in a high concentration of DMSO to induce cell death or in the specific MAPK/ERK pathway inhibitor Trametinib (TRA) (Figure 2d ). The addition of TRA reduced the red light-induced mCherry signal but not the mCerulean3 signal (Figure 2f) . In contrast the addition of DMSO lead to the reduction of both signals (Figure 2f ). Thus, taking advantage of spectral separation of CPH1S-o, we showed that effects of specific inhibitors can be distinguished from those of unspecific toxins in a single all-optical experiment. In future experiments, different colors of light may be used to independently activate two or more processes in the same cell or two or more cell types in a heterogeneous population to study cross-talk of cellular signaling pathways or cell-cell interactions.
An important trait of red light is its ability to penetrate tissue more deeply than blue and green light. Because experiments with blue light in mouse models often rely on implants or powerful light sources [3b, 15] , we tested if CPH1S-o can be activated directly and transdermally in tissues. Indeed, when illuminating HEK293 cells transfected with rtrkB-CPH1S-o through synthetic muscle, skin and skull ( Figure S5 ), we found potent activation of signaling ( Figure S6) . Notably, the applied light intensities were easily attained with light emitting diodes and even lower than those used in photodynamic therapy. [16] For mouse abdomen (including skin, muscle, fat and spine; thickness 10 mm) ( Figure S7 ), we found that the MAPK/ERK pathway was activated by red light in INS-1E cells transfected with mFGFR1-CPH1S-o (I = 3.0 mW cm -2 ,   647 ± 35 nm) ( Figure S8 ). We chose INS-1E cells, an insulinoma model for pancreatic β-cells [17] , for these experiments because β-cells signaling is regulated by FGFs and because β-cells are located  10 mm from the mouse skin. Collectively, these data show activation of cell signaling through mammalian tissues opening avenues to further non-invasive in vivo optogenetic studies. Light-sensitive proteins that undergo reversible inter-or intramolecular binding reactions are the motors of many optogenetic methods. By identifying and adapting the sensory domain of the cyanobacterial phytochrome CPH1, we introduced an approach for the stoichiometric, red light-induced homodimerization of proteins. Light-induced dimer assembly may be applied to regulate cell adhesion, gene transcription, or the cytoskeleton, potentially also by forming larger complexes after incorporation of multiple photoreceptor domains. 
Experimental Section

Phyotochrome sensory domains
Gene fragments coding for the sensory domain of two phytochromes, CPH1 from Synechocystis PCC6803 and the phytochrome of Cyanothece sp. ATCC51142 (C.s.), were amplified from genomic DNA libraries using polymerase chain reaction (PCR) (oligonucleotides 1-4, Table S1 ).
The sensory domain of the phytochrome of Nostoc sp. PCC7102 (N.s.) was amplified from cyanobacteria, which were lysed by boiling, using PCR (oligonucleotides 5 and 6, Table S1 ). In addition, gene fragments for the sensory domain of CPH1 and the phytochrome of Agrobacterium tumefaciens (A.t.) were synthesized with mammalian codon optimization according to the supplier's recommendation (Epoch Life Science, Inc.) and amplified using PCR (oligonucleotides 7-10, Table S1 ). Genes are given in Table S2 and S3.
Receptor tyrosine kinase fusion proteins
Phytochrome sensory domains were inserted into a mFGFR1 construct that was described previously [1] using PCR and the AgeI and XmaI restriction enzymes (see above for oligonucleotides). This construct contains the complete intracellular domain of mFGFR1, a myriostylation membrane anchor and a HA-epitope. rtrkB-CPH1S-o was generated using inverse PCR (oligonucleotides 11 and 12, Table S1 ). Starting from mFGFR1-CPH1S-o, amplification produced linear double-stranded DNA products with terminal SgrAI restriction sites that replace the mFGFR1 catalytic domain. Products were digested with SgrAI, ligated and propagated in E. coli cells. The rtrkB catalytic domain was then inserted using PCR and the BspEI and AgeI restriction enzymes (oligonucleotides 13 and 14, Table S1 ). Point substitutions in mFGFR1-CPH1S-o (Y271F, Y272F and R195E; numbered relative to start methionine of red light-activated mFGFR1) were introduced using site-directed mutagenesis (oligonucleotides 15-18, Table S1 ). For multi-color fluorescent reporter experiments, the CMV promoter in the mFGFR1-CPH1S-o expression vector was truncated for lower expression [2] using inverse PCR followed by blunt end ligation (oligonucleotides 19 and 20, Table S1 ). All constructs were verified by DNA sequencing and sequences are given in Table S4 .
Fluorescent transcriptional reporters
Fluorescence transcriptional reporters (Table S5) were generated by first removing the luciferase gene from the pGL4.33 vector (Promega) using inverse PCR and the AscI restriction enzyme (oligonucleotides 21 and 22, Table S1 ). Genes coding for mCerulean3 or mCherry, kind gifts of R.Y. Tsien and M. Davidson, were inserted using PCR (oligonucleotides 23-26, Table   S1 ).
Cell culture
HEK293 cells were maintained in DMEM and INS-1E cells [3] , a kind gift of P. Maechler, were maintained in RPMI-1640 in a humidified incubator with 5 % CO 2 atmosphere (37 °C). DMEM was supplemented with 10 % FBS, 100 U/ml penicillin and 0.1 mg/ml streptomycin, and RPMI-1640 was additionally supplemented with 10 mM HEPES, 1 mM pyruvate, 2 mM L-Glutamine and 50 µM β-mercaptoethanol. HEK293 cells were transfected using polyethylenimine (Polysciences) and INS-1E cells were transfected using Lipofectamine 2000 (Invitrogen/Life Technologies) (see below).
Sensory domain expression and cell viability
An expression plasmid based on pcDNA3.1(-) was used in which a BspEI restriction site was placed after the fluorescent protein mVenus [4] and a glycine-and serine-rich linker. Biorad) was applied at a dilution of 1:10000 for 2 h at RT.
Synthetic tissues and MAPK/ERK pathway activation
Synthetic tissues whose spectral properties match those of human skin, skull and muscle [5] were prepared by supplementing high purity 2 % agarose gels (Carl Roth) with dyes (Sigma) depending on tissue type ( Figure S5 ). Synthetic skin was generated by supplementing 104.5 ml gel with 50 µg tartrazine and 3 µg amaranth. Synthetic muscle was generated by supplementing with 15 µg tartrazine and 15 µg amaranth. Synthetic skull was generated by supplementing 31.4 ml gel with 75 µg tartrazine, 55 µg allura red AC, 10 µg amaranth, 25 µg prussian blue and 50 µg brilliant blue. 10 mm of synthetic tissue correspond to 10 mm of animal tissue, except for skin which has 20-fold higher absorption (in this case, 10 mm of synthetic tissue correspond to 0.5 mm of mammalian skin). HEK293 cells transiently transfected with rtrkB-CPH1S-o were illuminated through the synthetic tissues and further processed for luminescence measurements as described above.
Determination of tissue penetration through animal tissue
For measuring light penetration through head, the lower jaw and the palate bone of three shaved mouse heads were removed to create an opening (light that penetrated through the shaved scalp, the skull and the whole brain was measured). For mouse abdomen, shaved mouse torso was opened (light that penetrated through shaved skin, fat, muscle, spine and organs was measured). For illumination, a bright lamp (DG4, Sutter instruments) and a dish covered with black tape with a window was placed above a sensor connected to a power meter ( Figure S7b ). Three measurements were acquired each first without sample (to determine the initial light intensity, I 0 , in µW cm -2 ) and then with the sample (to determine transmission, T, in µW cm -2 ). All measurements were made in triplicates and penetration was calculated as T / I 0 .
Activation of INS-1E cells through animal tissue
Because the synthetic tissues were optimized to mimic absorption but not scattering properties,
we also performed experiments with mouse tissues. 1.5 x 10 6 INS-1E cells were seeded in a 35 mm dish and transfected with 2.5 µg total DNA per dish (receptor and empty vector at a ratio of 1:50). 9.5 h after transfection, medium was replaced with 1.5 ml reduced serum starve medium supplemented 10 µM PCB and incubated for 18 h in the dark. Mouse abdomen including shaved skin, fat, muscle, and spine was placed in a 35 mm cell culture dish. The dish was covered with black tape, except for a window at its bottom and top. Cells were illuminated for 15 min with red light (I = 3.0 mW cm -2 ,   647 ± 35 nm) through the mouse abdomen. Cells were then immediately washed, lysed, and processed as described above (dark and mock transfection (m.t) controls were also treated as described above). 30 μl lysate per lane were separated by SDS-PAGE and electro-blotted onto PVDF membranes. Blots were incubated with primary antibody (pERK1/2 #9101, dilution 1:1000, Cell Signaling) in blocking solution overnight at 4 °C and secondary antibody for processing as described above. Figure Supporting Tables   Table S1 . 
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